Open AccessHigher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123--ETOILE)
Author(s) -
Véronique Avettand-Fènoël,
Vincent Bouteloup,
A. Melard,
Catherine Fagard,
MarieLaure Chaix,
Pascale Leclercq,
Geneviève Chêne,
JeanPaul Viard,
C Rouzioux
Publication year - 2010
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq282
Subject(s) - medicine , human immunodeficiency virus (hiv) , salvage therapy , sida , immunology , viral disease , chemotherapy
To describe HIV-1 DNA levels from baseline (W0) to week 52 (W52) among patients receiving either interleukin-2 (IL-2) + optimized background therapy (OBT) or OBT as salvage treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom